ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hair loss treatment DA-001 enters Large-Scale human testing
Disease control Not yet recruitingThis study tests a treatment called DA-001 for people with hair shedding or hair loss conditions like telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment to their scalp to see if it reduces shedding and helps hair grow back. The stud…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated May 01, 2026 21:58 UTC
-
One-shot hair fix? new study tests nanofat against daily creams
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat tissue) works better than either platelet-rich plasma (PRP) injections or daily topical minoxidil for male and female pattern baldness. Sixty adults aged 18-50 with confirmed androgenetic alopecia will be enrol…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 01, 2026 16:11 UTC
-
New pill could help men regrow hair – phase 3 trial begins
Disease control Not yet recruitingThis study tests an oral medication called N1087 (a form of minoxidil) to see if it can help men with male pattern baldness regrow hair. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo daily for 24 weeks. The main goal is to measure chan…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC